Ambu A/S (OTCMKTS:AMBBY) Sees Strong Trading Volume – Here’s What Happened

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) shares saw an uptick in trading volume on Thursday . 1,500 shares were traded during trading, an increase of 106% from the previous session’s volume of 729 shares.The stock last traded at $10.20 and had previously closed at $10.00.

Ambu A/S Stock Performance

The stock’s 50-day moving average is $11.88 and its 200-day moving average is $13.49. The stock has a market cap of $2.40 billion, a price-to-earnings ratio of 32.90 and a beta of 1.25. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.86 and a quick ratio of 1.67.

Ambu A/S (OTCMKTS:AMBBY) last announced its earnings results on Wednesday, February 4th. The company reported $0.07 earnings per share (EPS) for the quarter. Ambu A/S had a net margin of 8.86% and a return on equity of 9.15%. The firm had revenue of $242.85 million for the quarter.

Ambu A/S Company Profile

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.